| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Annemieke Aartsma-Rus
|
|
|
|
19 |
5 |
p. 388
|
artikel
|
| 2 |
A pragmatic, personalised approach to treatment initiation in Parkinson's disease
|
Schapira, Anthony H V
|
|
|
19 |
5 |
p. 376-378
|
artikel
|
| 3 |
Babinski: a poet of neurology
|
Drouin, Emmanuel
|
|
|
19 |
5 |
p. 388
|
artikel
|
| 4 |
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
|
Karikari, Thomas K
|
|
|
19 |
5 |
p. 422-433
|
artikel
|
| 5 |
Can we trust The End of Alzheimer's?
|
MD, Joanna Hellmuth
|
|
|
19 |
5 |
p. 389-390
|
artikel
|
| 6 |
Correction to Lancet Neurol 2020; 19: 197–98
|
|
|
|
19 |
5 |
p. e5
|
artikel
|
| 7 |
Evidence-based support for autistic people across the lifespan: maximising potential, minimising barriers, and optimising the person–environment fit
|
Lai, Meng-Chuan
|
|
|
19 |
5 |
p. 434-451
|
artikel
|
| 8 |
Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
|
Zhao, Hua
|
|
|
19 |
5 |
p. 383-384
|
artikel
|
| 9 |
Initiation of pharmacological therapy in Parkinson's disease: when, why, and how
|
de Bie, Rob M A
|
|
|
19 |
5 |
p. 452-461
|
artikel
|
| 10 |
Intensive medical management of intracranial arterial stenosis
|
Uchiyama, Shinichiro
|
|
|
19 |
5 |
p. 371-373
|
artikel
|
| 11 |
Interleukin-6 receptor blockade for the treatment of NMOSD
|
Levy, Michael
|
|
|
19 |
5 |
p. 370-371
|
artikel
|
| 12 |
Long-term unsupervised mobility assessment in movement disorders
|
Warmerdam, Elke
|
|
|
19 |
5 |
p. 462-470
|
artikel
|
| 13 |
Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study
|
Hurford, Robert
|
|
|
19 |
5 |
p. 413-421
|
artikel
|
| 14 |
Refining endpoints for stroke recovery trials
|
Hermann, Dirk M
|
|
|
19 |
5 |
p. 381-382
|
artikel
|
| 15 |
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
|
Traboulsee, Anthony
|
|
|
19 |
5 |
p. 402-412
|
artikel
|
| 16 |
Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
|
Zhang, Chao
|
|
|
19 |
5 |
p. 391-401
|
artikel
|
| 17 |
Setting the research agenda to secure the wellbeing of autistic people
|
Hudry, Kristelle
|
|
|
19 |
5 |
p. 374-376
|
artikel
|
| 18 |
Smartphones versus Parkinson's disease: i-PROGNOSIS
|
Burton, Adrian
|
|
|
19 |
5 |
p. 385-386
|
artikel
|
| 19 |
Social media could address the gender gap in neurosurgery
|
Norton, Emma Jane
|
|
|
19 |
5 |
p. 382-383
|
artikel
|
| 20 |
The fight against stroke must go on
|
The Lancet Neurology,
|
|
|
19 |
5 |
p. 369
|
artikel
|
| 21 |
The transformative potential of plasma phosphorylated tau
|
Jack Jr, Clifford R
|
|
|
19 |
5 |
p. 373-374
|
artikel
|
| 22 |
Unanswered questions from the Evoke trial
|
Maher, Chris
|
|
|
19 |
5 |
p. 380
|
artikel
|
| 23 |
Unanswered questions from the Evoke trial – Author's reply
|
Mekhail, Nagy
|
|
|
19 |
5 |
p. 380-381
|
artikel
|
| 24 |
Wearable-based mobility monitoring: the long road ahead
|
Fasano, Alfonso
|
|
|
19 |
5 |
p. 378-379
|
artikel
|
| 25 |
Werner Hacke: a new era for stroke patients
|
Morgan, Jules
|
|
|
19 |
5 |
p. 387
|
artikel
|
Tijdschrift beschrijving